Highlights

  • Zycov D likely to be available from October
  • Deemed safe for children above 12 years of age
  • 3 doses with 28 day intervals recommended

Latest news

Asus Pad T3201 Review: OLED Brilliance Meets Everyday Mid-Range Power

Asus Pad T3201 Review: OLED Brilliance Meets Everyday Mid-Range Power

Qualcomm Showcases Snapdragon 8 Elite Gen 6 Chips At IMC 2026, Teases New Flagships

Qualcomm Showcases Snapdragon 8 Elite Gen 6 Chips At IMC 2026, Teases New Flagships

Shokz Diwali Sale Brings Discounts On Open-Ear Headphones Across Amazon And Flipkart

Shokz Diwali Sale Brings Discounts On Open-Ear Headphones Across Amazon And Flipkart

iQOO 16 Confirmed For India With Snapdragon 8 Elite Extreme Gen 6 And OriginOS 7

iQOO 16 Confirmed For India With Snapdragon 8 Elite Extreme Gen 6 And OriginOS 7

ASUS Announces Festive Discounts Across Laptops, Gaming PCs And Tablets

ASUS Announces Festive Discounts Across Laptops, Gaming PCs And Tablets

Priyanka Gandhi lies on ground, Rahul detained as Delhi Police stop INDIA bloc MPs' Jantar Mantar march

Priyanka Gandhi lies on ground, Rahul detained as Delhi Police stop INDIA bloc MPs' Jantar Mantar march

Emotion, tears as Messi retires from Argentina national team

Emotion, tears as Messi retires from Argentina national team

Rajpal Yadav tells CJI Surya Kant his legal troubles inspired film title ‘Solah Sawan Jhel Ke’

Rajpal Yadav tells CJI Surya Kant his legal troubles inspired film title ‘Solah Sawan Jhel Ke’

Meet ZyCoV-D: The world’s first DNA Covid-19 vaccine; everything you need to know about the new vaccine

The shot is “the world’s first and India’s indigenously developed DNA-based vaccine for Covid-19 to be administered in humans including children and adults 12 years and above.”

Meet ZyCoV-D: The world’s first DNA Covid-19 vaccine; everything you need to know about the new vaccine

Zydus Cadila's covid vaccine ZyCoV-D is set to be launched in India in October and is deemed for safe for kids above 12. This 'third-generation triple dose vaccine' could just be the answer to fill the gap of 100 crore doses required by year-end to vaccinate the vast majority of the adult population. Here is everything you need to know about this non-injecting, DNA vaccine which even children above 12 can take.

Meet Cadila’s ZyCoV-D

  • It is the world’s first DNA vaccine to protect against Covid 19. Requires a triple dose for immunity and showcased 67% efficacy in trials. The vaccine is deemed safe for children above the age of 12.

What kind of vaccine is it? How is it different than Covishield and Covaxin?

  • Cadila’s ZyCoV-D is a plasmid DNA vaccine that introduces a DNA sequence encoding the antigen in the body and not a weakened form of the pathogen like Covaxin.

How does a DNA vaccine work?

  • Often referred to as the third-generation vaccines, the dose carries the genetic code of the virus that triggers the build up of immunity in one's body.
  • Zydus stated that the plasmid DNA platform is “ideally suited for dealing with Covid-19 as it can be easily adapted to deal with mutations in the virus, such as those already occurring”.

Is a DNA vaccine being used anywhere else in the world?

  • No DNA vaccine has been widely used against any disease so far, but they are more stable and easier to store than mRNA shots (tech used by Pfizer & Moderna)
  • According to the U.S. National Library of Medicine, over 160 different DNA vaccines are currently being tested in human clinical trials in the United States. It is estimated that 62% of these trials are devoted to cancer vaccines and 33% are applied for vaccines against human immunodeficiency virus (HIV).

How many doses does one need?

  • Unlike most other Covid-19 vaccines, which require two doses for full immunity, ZyCoV-D is administered in three doses. The vaccine is also needle-free.
  • The doses will be administered 28 days apart

Needle-free vaccine, how does one get the dose?

  • Doses are given using a device that delivers fluid through a spring-powered jet that penetrates the skin, developed by Pharmajet’s Tropis.
  • Zydus Cadila claims this method of delivery is painless and could also reduce side effects from the jab

Is it safe? What are the trial results showing?

  • The vaccine has been tested on almost 30,000 participants across Phase I, II and III studies, and is the first vaccine in India to be tested on 12 to 18-year-olds. Around 1,000 participants were enrolled in the adolescent age group, among whom the vaccine was found to be safe and well-tolerated, with similar findings in the adult population

Frequently Asked Questions

ZyCoV-D is the world's first DNA Covid-19 vaccine, set to be launched in India in October. It is a plasmid DNA vaccine that introduces a DNA sequence encoding the antigen in the body, requiring a triple dose for immunity and shown to be 67% effective in trials.

ADVERTISEMENT

Up Next

Meet ZyCoV-D: The world’s first DNA Covid-19 vaccine; everything you need to know about the new vaccine

Meet ZyCoV-D: The world’s first DNA Covid-19 vaccine; everything you need to know about the new vaccine

Sensex falls 429 points, Nifty slips 173 points after RBI rate hike

Sensex falls 429 points, Nifty slips 173 points after RBI rate hike

RBI raises repo rate by 25 bps to 5.50%, shifts policy towards tightening

RBI raises repo rate by 25 bps to 5.50%, shifts policy towards tightening

GST rates likely unchanged as 57th Council meeting focuses on reforms

GST rates likely unchanged as 57th Council meeting focuses on reforms

Sensex gains 685 points, Nifty rises 220 points to cross 22,700

Sensex gains 685 points, Nifty rises 220 points to cross 22,700

Sensex gains 473 points, Nifty rises 134 points as markets stage recovery

Sensex gains 473 points, Nifty rises 134 points as markets stage recovery

ADVERTISEMENT

editorji-whatsApp

More videos

India To Grow 7% In FY27, Next Growth Phase Hinges On Infra, Deeper Capital Markets: S&P Global

India To Grow 7% In FY27, Next Growth Phase Hinges On Infra, Deeper Capital Markets: S&P Global

Sensex Falls 49 Points, Nifty Slips 96 As Selling Pressure Returns

Sensex Falls 49 Points, Nifty Slips 96 As Selling Pressure Returns

Sensex falls 243 points, Nifty slips 64 points as foreign outflows and crude prices weigh

Sensex falls 243 points, Nifty slips 64 points as foreign outflows and crude prices weigh

India launches anti-dumping probes into 7 Chinese products, including key pharma ingredients

India launches anti-dumping probes into 7 Chinese products, including key pharma ingredients

Sensex crashes 1,124 points, Nifty falls 1.56% as crude surges above $107

Sensex crashes 1,124 points, Nifty falls 1.56% as crude surges above $107

Sensex Rises 315 Points, Nifty Gains 77 as Markets Recover After Sharp Sell-Off

Sensex Rises 315 Points, Nifty Gains 77 as Markets Recover After Sharp Sell-Off

Sensex Crashes 1,248 Points, Nifty Falls 1.64% Amid Global Cues

Sensex Crashes 1,248 Points, Nifty Falls 1.64% Amid Global Cues

Sensex, Nifty End Higher As Domestic Growth Signals, Softer Crude Support Sentiment

Sensex, Nifty End Higher As Domestic Growth Signals, Softer Crude Support Sentiment

UPI Payments In Uzbekistan: Indian Travellers To Get QR-Based Payment Option

UPI Payments In Uzbekistan: Indian Travellers To Get QR-Based Payment Option

India’s Q1 GDP Growth Hits 7.8%, Beats RBI Estimate

India’s Q1 GDP Growth Hits 7.8%, Beats RBI Estimate

Editorji Technologies Pvt. Ltd. © 2022 All Rights Reserved.